Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

SW033291

SW033291 is a potent and selective 15-PGDH inhibitor with a Ki of 0.1 nM. It elevates tissue PGE2 levels and is utilized in research on tissue regeneration, hematopoiesis, and inflammation, with demonstrated applications in both in vitro assays and in vivo rodent models.

Product Specifications

CAS Number

459147-39-8

Product Name Alternative

Prostaglandin, SW033291, SW-033291, SW 033291, Peripheral, PGE2, marrow, Inhibitor, hematopoietic, neutrophil, inhibit, knockout, bone, 15-Hydroxyprostaglandin dehydrogenase, 15-PGDH

Field of Research

Metabolism Research

Purity

97.26% (May vary between batches)

Solubility

10% EtOH+90% Corn Oil:0.5 mg/mL (1.21 mM) ; DMSO:41.3 mg/mL (100.1 mM) ; Ethanol:8.3 mg/mL (20.12 mM)

Smiles

CCCCS (=O) c1sc2nc (cc (-c3ccccc3) c2c1N) -c1cccs1

Molecular Formula

C21H20N2OS3

Molecular Weight

412.59

Storage Conditions

-20°C

Notes

For research use only.

Available Sizes

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

PcDNA3.1-Flag-CASP8
PPL00872-2a 1 Each

PcDNA3.1-Flag-CASP8

Sign In for Pricing
View Details
1-[2- (Trifluoromethyl) phenyl]-1H-pyrazole-3-carboxylic acid
CWB81538-01 100 mg

1-[2- (Trifluoromethyl) phenyl]-1H-pyrazole-3-carboxylic acid

Sign In for Pricing
View Details
1-[2- (Trifluoromethyl) phenyl]-1H-pyrazole-3-carboxylic acid
CWB81538-02 1 g

1-[2- (Trifluoromethyl) phenyl]-1H-pyrazole-3-carboxylic acid

Sign In for Pricing
View Details
Lentiviral human VPS29 shRNA (UAS) - Lentiviral human VPS29 shRNA (UAS, GFP) (25)
GTR15143756 1 Vial

Lentiviral human VPS29 shRNA (UAS) - Lentiviral human VPS29 shRNA (UAS, GFP) (25)

Sign In for Pricing
View Details
TPM4 Protein Vector (Human) (pPM-C-HA)
PV043567 500 ng

TPM4 Protein Vector (Human) (pPM-C-HA)

Sign In for Pricing
View Details
TGF alpha Antibody
V7158IHC-7ML 7 mL

TGF alpha Antibody

Sign In for Pricing
View Details